AUTL vs QRVO · rev $71.9M vs P/E 27, rev $3.68B
Autolus Therapeutics Ltd (AUTL) versus Qorvo Inc (QRVO) — a side-by-side from cached financials, not a winner call.
Autolus Therapeutics Ltd (AUTL) is a biotechnology company listed on US.
Qorvo Inc (QRVO) is a semiconductors company listed on NASDAQ.
Latest reported AUTL revenue for 2026-06-30 was $71.9M. Net income was -$110.7M. AUTL currently screens at market cap $614.8M.
Latest reported QRVO revenue for 2026-03-28 was $3.68B. Net income was $339.0M. Revenue was down 1.1% from 2025-03-29 to 2026-03-28. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
AUTL currently screens at market cap $614.8M. QRVO currently screens at market cap $8.54B and trailing P/E 26.8.
Not investment advice. Open the AUTL and QRVO stock pages for the full models.
Not investment advice.